Business Context and Reporting Period
This Form 8-K, dated December 22, 2023 and filed by Nukkleus Inc. (formerly Brilliant Acquisition Corporation), reports completion of the business combination with Nukkleus Inc. (referred to as Old Nukk). The provided request metadata identifies T3 Defense Inc., but the filing itself identifies Nukkleus Inc. as the registrant.
Brilliant domesticated from the British Virgin Islands to Delaware, adopted amended organizational documents, and changed its name to Nukkleus Inc. Old Nukk survived the merger as a wholly owned subsidiary. The transaction closed on December 22, 2023, and Nukkleus common stock and warrants began trading on Nasdaq on December 26, 2023 under NUKK and NUKKW.
Key Financial and Capitalization Information
- 330,345 Brilliant ordinary shares were redeemed for approximately $3.82 million, at approximately $11.57 per share.
- Immediately following the transaction, Nukkleus had 13,899,713 common shares and 6,701,000 warrants outstanding.
- Old Nukk stockholders owned approximately 78.3% of the combined company; Brilliant public stockholders owned approximately 0.5%; and Brilliant’s sponsor, officers, directors, and advisors owned approximately 8.0%.
- The transaction exchanged all Old Nukk common stock for a pro rata portion of 10,500,000 Nukkleus shares.
- Old Nukk options were assumed and converted using a 1:35 exchange ratio, with corresponding adjustments to shares subject to the options and exercise prices.
- The filing does not provide current post-closing revenue, net income, operating cash flow, margins, debt, cash balance, or liquidity figures. Historical and pro forma financial information is incorporated by reference from the Joint Proxy Statement/Prospectus and prior periodic filings.
- Nukkleus stated that neither Old Nukk nor Brilliant had paid cash dividends and that Nukkleus did not presently plan to pay dividends in the foreseeable future.
Material Changes Versus the Prior Comparable Period
- Brilliant ceased to be a shell company following completion of the business combination.
- The registrant changed its legal name, jurisdiction of incorporation, corporate charter, bylaws, securities registrations, and Nasdaq trading symbols.
- Brilliant’s former directors and officers resigned in connection with the closing. Emil Assentato became Chairman and Chief Executive Officer, Jamal Khurshid became Director and Chief Operating Officer, and Tony Porcheron became Chief Financial Officer.
- The combined company entered into a two-year lock-up agreement covering specified securities held by the sponsor, certain former Brilliant holders, and certain former Old Nukk equity holders.
- Nukkleus agreed to file a resale shelf registration statement for specified securities no later than 45 business days after closing and granted customary demand and piggyback registration rights.
Guidance, Outlook, Management Commentary, Risks, and Unusual Items
The filing does not provide specific numerical revenue, earnings, cash flow, or operating guidance. It references planned financial infrastructure development in a December 29, 2023 press release and investor presentation, but the detailed contents are not included in the provided filing text.
- Nukkleus described risks arising from its limited operating history, rapid acquisition-driven growth, intense competition, and uncertain ability to sustain growth or profitability.
- Key operating risks include dependence on significant customers and partners, foreign-exchange market conditions affecting FXDD, cybersecurity incidents, technology disruptions, and reliance on third parties.
- The company highlighted evolving regulation affecting financial services, blockchain technology, digital assets, and international operations.
- Nukkleus may require additional capital to fund growth, but such capital may be unavailable or may require shareholder approval.
- The transaction involved significant dilution and ownership changes, including 6,701,000 outstanding warrants and registration rights that could facilitate future resales.
Important Facts for Investors to Verify
- Confirm that Nukkleus Inc., rather than T3 Defense Inc., is the registrant covered by this filing.
- Review the incorporated historical and pro forma financial statements for revenue, profitability, cash, debt, liquidity, and transaction accounting.
- Verify the final number of shares and warrants outstanding, including the effect of assumed options, redemptions, the backstop pool, and potential warrant exercises.
- Review the lock-up terms, registration rights, and potential resale-related dilution.
- Assess the company’s ability to fund operations and growth, particularly given the absence of current liquidity metrics in this 8-K.
- Review the Joint Proxy Statement/Prospectus risk factors and the company’s subsequent Forms 10-K and 10-Q for updated operating performance and contingencies.